Vigil Neuroscience, Inc. (VIGL): insider trading, Congress trades & who owns it

Insider signal
43/100
Neutral · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
—
13F filings
Congress trades
None
none in 2 years

Quiet on the insider front: nobody at Vigil Neuroscience, Inc. bought or sold VIGL shares at market prices this past year.

Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.

Want the full picture on VIGL? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full VIGL report — free account

Latest insider trades in VIGL

FiledInsiderRoleTypeSharesPriceValueSource
Dec 19, 2024Budd Haeberlein Samantha L.DirectorBuy12,000$1.71$21KSEC
Dec 19, 2024Magovcevic-Liebisch IvanaCEOBuy5,000$1.68$8KSEC
Dec 18, 2024Magovcevic-Liebisch IvanaCEOBuy5,000$1.67$8KSEC
Dec 5, 2024Magovcevic-Liebisch IvanaCEOBuy5,000$2.34$12KSEC
Nov 20, 2023Magovcevic-Liebisch IvanaCEOBuy4,000$3.75$15KSEC

Questions about VIGL

Are insiders buying or selling VIGL stock?

There were no open-market insider trades in VIGL in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

Has any member of Congress traded VIGL?

No congressional trades in VIGL were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).